Alphabet Looks to Raise About $15 Billion From US Bond Sale

<p>Watch Scarlet and Paul LIVE every day on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.<br /><br />Market news and in-depth company research.<br /><br />Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu<br /><br />-Robert Schiffman, Senior Tech Credit Analyst for Bloomberg Intelligence, discusses &nbsp;Alphabet looking to raise about $15 billion from a US high-grade dollar bond sale, adding to a borrowing spree by companies at the forefront of the artificial intelligence investment boom.<br /><br />-Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses the latest in the biotech sector. Eli Lilly &amp; Co. is paying $350 million upfront to collaborate with Innovent Biologics Inc. in developing new treatments for cancer and immune disorders. Novo Nordisk A/S is suing Hims &amp; Hers Health Inc. for breaching its US patent on semaglutide, the active ingredient in medicines like Ozempic and Wegovy.<br /><br />-Scott Levine, Bloomberg Intelligence Senior Energy Services Analyst, discusses Transocean agreeing to acquire the offshore drilling firm in an all-stock transaction valued at approximately $5.8 billion. Valaris shareholders will receive a fixed exchange ratio of 15.235 shares of Transocean stock for each common share of Valaris.<br /><br />-Drew Reading, Bloomberg Intelligence U.S Homebuilding Analyst, discusses why a potential antitrust probe into US homebuilders by the Trump Administration -- as reported by Bloomberg News -- may prove to be more political than driven by illicit behavior.</p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>